ICON plc - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for ICON plc Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

ICON plc. The Group's principal activity is providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. The Group operates offices in 71 locations in 38 countries worldwide. During the 2008 the Group acquired 100% of Healthcare Discoveries Inc. and Prevalere Life Sciences Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report